Mucosal immunity in Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 7 SUPPL. 1, 2004, Pages

  Neurath, Marku F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 23; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; NATALIZUMAB; TUMOR NECROSIS FACTOR ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MUCOSAL IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 1542619850     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200402001-00006     Document Type: Article

References (23)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
2. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that Is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812-4818.
3. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
4. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology. 2003;125:47-57.
5. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-382.
6. Duchmann R, Zeitz M. 1998. Crohńs disease. In: Handbook of mucosal immunology. P. Ogra, and W. Strober, editors. Academic Press.
7. D'Haens, GR, Geboes K, Peeters M, et al. 1998. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterologv:262-267.
8. Sartor R. Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology. 1998;114:398-400.
9. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nature Med. 2002;8:567-573.
10. Greenwald B, James SP. Long-term HIV infection with Crohn's disease. Am J Gastroenterol. 1995;90:167-168.
11. Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology. 1998; 114:433-440.
12. Hove, T.t., C.v. Montfrans, M.P. Peppelenbosch, and S.J.v. Deventer. 2002. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut. 50:206-211.
13. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003;111:1133-1145.
14. Ghosh S, Goldin E, Gordon FH, et al. Natalizumab for active Crohn's disease. N Engl J Med. 2003;348:24-32.
15. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521-533.
16. Oppmann B., Lesley R, Blom B, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biologic activities similar as well as distinct from IL-12. Immunity. 13:715-725.
17. Pizarro TT, Michie MH, Bentz M, et al. IL-18, a novel immunoregulatory cytokine, is upregulated in Crohńs disease: expression and localization in intestinal mucosal cells. J Immunol. 1999;162:6829-6835.
18. Monteleone G, Trapasso F, Parello T, et al. Bioactive IL-18 expression is upregulated in Crohńs disease. J Immunol. 1999;163:143-147.
19. Neurath MF, Weigmann B, Finotto S, et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohńs disease. J Exp Med. 2002;195:1129-1143.
20. Szabo SJ, Sullivan BM, Stemmann C, et al. T-bet is Essential for Th1 Lineage Commitment and IFN-gamma production in CD4 but not CD8 T Cells. Science. 2002;295:338-342.
21. Neurath MF, Finotto S, Fuss I, et al. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol. 2001;22:21-26.
22. Deventer, S.J.v. 2001. Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease. Gastroenterology. 121:1242-1246.
23. Holtmann MH, Douni E, Schütz M, et al. Tumor necrosis factor-receptor 2 is upregulated on lamina propria T cells in Crohńs disease and promotes experimental colitis in vivo. Eur J Immunol. 2002;32:3142-3151.